Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects

NCT01018927 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2017-05-31

No results posted yet for this study

Summary

The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.

Conditions

Interventions

DEVICE

Administering three additional MRI images

Three additional MRI images to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration

Sponsors & Collaborators

  • Siemens Molecular Imaging

    collaborator INDUSTRY
  • University of Arkansas

    lead OTHER

Principal Investigators

  • Tarun Pandey · University of Arkansas for Medical Sciences (UAMS)

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2017-05-30
Completion
2017-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01018927 on ClinicalTrials.gov